newsfilter
← Latest News
GlobeNewswire·

Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation

Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating combination with ivacaftor by the en